Effects of Epetôme on Gastrointestinal Function, Inflammation and Wellbeing in Adults With IBS-like Symptoms (EPEGUT)
Many adults live with uncomfortable digestive problems like bloating, stomach pain, and irregular bowel habits, even if they have not been diagnosed with Irritable Bowel Syndrome (IBS). These symptoms can affect daily life and wellbeing. Scientists believe that supporting the balance of bacteria in the gut may help calm these issues. The EPEGUT study is looking at an everyday food supplement called Epetôme. It combines 'good' bacteria (probiotics) with plant fibres that nourish them (prebiotics). Researchers want to find out if taking Epetôme daily for 12 weeks improves gut comfort, reduces inflammation, and lifts general wellbeing compared to an inactive dummy supplement (placebo). The trial is open to UK adults aged 35 to 50 who regularly deal with digestive discomfort but do not have an official diagnosis of IBS or other chronic bowel diseases.
At a glance
What is this study about?
Many people regularly experience gut troubles such as cramping, trapped wind, bloating, or unpredictable trips to the toilet. Even without a formal medical condition, these ongoing symptoms can make everyday life, eating out, and working uncomfortable and stressful.
Inside our digestive system live trillions of microscopic organisms, known as the gut microbiome. These friendly bugs help digest our food, support our immune defences, and communicate with the brain. When this natural community gets out of balance, it can lead to gut irritation, slow digestion, and low-level inflammation. Probiotics (live friendly bacteria) and prebiotics (special plant fibres that feed good bacteria) are often used to help restore this natural balance.
Epetôme is a food supplement that combines both prebiotics and probiotics in one product. The goal of this study is to see if combining these ingredients can improve everyday gut health better than a dummy pill (placebo). Over 12 weeks, researchers will measure how the supplement affects gut comfort, markers of inflammation in the body, and day-to-day quality of life.
By taking part, volunteers can help researchers learn whether simple, food-based supplements are an effective way to manage everyday tummy troubles and support long-term digestive health.
Key takeaways
- Tests a daily combined prebiotic and probiotic supplement (Epetôme) over 12 weeks.
- Aimed at UK adults aged 35 to 50 with persistent tummy troubles like bloating and cramps.
- Participants must not have a formal diagnosis of IBS or other digestive diseases.
- Requires providing stool, urine, saliva, and blood samples at set points.
- You have an equal chance of receiving the active supplement or an inactive placebo.
Who may be eligible?
To join this study, you must be a generally healthy adult aged between 35 and 50 who lives in the UK. You should have ongoing, noticeable gut symptoms—such as tummy pain, bloating, or changes in how often you use the toilet—even though you are otherwise well.
Because researchers want to study everyday gut troubles, you cannot take part if a doctor has formally diagnosed you with Irritable Bowel Syndrome (IBS), inflammatory bowel disease, or another serious, long-term health condition. You also cannot join if you take medications that directly change how your gut works, such as regular laxatives or immune-suppressing drugs.
In addition, you must not have used antibiotics in the past three months, or taken probiotic or prebiotic supplements in the past four weeks. You should be eating your usual diet without starting any strict new weight-loss plans, and you must be willing to provide stool, urine, saliva, and blood samples during the trial.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am aged between 35 and 50 and live in the UK.
- I regularly experience tummy aches, bloating, or altered bowel habits.
- I have never been formally diagnosed with IBS or another serious bowel disease.
- I have not taken antibiotics in the last 3 months.
- I have not used probiotic or prebiotic supplements in the last 4 weeks.
- I am willing to provide blood, stool, saliva, and urine samples.
What does participation involve?
Taking part in this study lasts for 12 weeks. During this time, you will take either the Epetôme supplement or an inactive dummy supplement (placebo) every day. You will not know which one you receive until the trial ends. You will be asked to keep to your normal eating habits and avoid starting any new gut supplements. Throughout the study, you will complete questionnaires about your digestive comfort and overall wellbeing. You will also need to provide biological samples at set times, including blood samples, saliva, a morning urine sample, and stool samples to check your gut bacteria and inflammation levels.
Potential risks and benefits
Locations (1)
- University of Roehampton, School of Life and Health SciencesVerified postcodeLondon, United Kingdom
Common questions
What is Epetôme?
Epetôme is a food supplement that blends live friendly bacteria (probiotics) with prebiotic fibres designed to nourish and support a healthy gut.
Can I join if a doctor has already diagnosed me with IBS?
No. This study is specifically looking at adults with IBS-like symptoms who have not received a formal medical diagnosis of IBS or another bowel condition.
Will I definitely receive the active supplement?
No. Half of the participants will receive Epetôme, and the other half will receive an inactive dummy pill (placebo) so researchers can make a fair comparison.
Can I continue taking my own vitamins or probiotics?
General multivitamins are usually fine, but you must stop taking any other prebiotic, probiotic, or high-fibre supplements for the duration of the study.
Does it cost anything to take part?
No, taking part is free. All study materials, supplements, and sample collection kits are provided at no cost to you.
How to find out more
Savriniso Nazarova-Lewis
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.